Vitamin d derivatives

Vitamin D2 derivatives
Vitamin D4
Vitamin D3 derivatives

 

 

Eldecalcitol,104121-92-8
Eldecalcitol
Eldecalcitol,104121-92-8
Product Name
Eldecalcitol
Synonyms
ED 71
Systematic Name
2-(3-Hydroxypropoxy)calcitriol
CAS No.
104121-92-8
Molecular Formula 
N.A
Molecular Weight
490.7
Intermediate
Pro-eldecaltitol (n-4 step) CAS:151546-09-7
COA
COA_Eldecalcitol,104121-92-8
View via PDF file
Eldecalcitol,104121-92-8
Impurities
1
>98% 10mg/50mg
2
>93% 10mg/50mg
3
>93% 10mg/50mg
Spectrums
H-NMR,C-NMR/Mass/HPLC/IR/UV are available
Specification
Items
Specification
Test result
Appearance
White to off-white crystalline powder
Complies
Identification
HPLC
Complies
Solubility
Corresponds
Complies
HPLC
> 98.0%
99.2%
Single impurity
< 1.0%,
0.04%
Total impurities
< 2.0%,
0.2%
Each unkonwn
< 1.0%,
<0.1%
Loss on drying
< 1.0%,
ND
Assay
97.0% - 103.0%
99.5%
Contact us for more information
Chemical information
Compound Name*
CAS No. "N/A" if the CAS not available*
Quantity*
Contact information
Contact person*
Email Address *
Tel No.*
Company or Organization Name*
Shipping Address*
Country
Remarks

<Privacy policy: the contact information will be only used for this business contact>

Related Vitamin D3 derivatives
Calcitriol EPVII [HOT]
Patent Disclaimer
PD1
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
PD2
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
PD3
the buyer assumes responsibility of all patent considerations in the use of
Lanos' Pharmaceutical Co.,LTD ’s product(Eldecalcitol,104121-92-8).
PD4
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.